These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24568147)

  • 21. Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia.
    Wojnarski B; Lon C; Sea D; Sok S; Sriwichai S; Chann S; Hom S; Boonchan T; Ly S; Sok C; Nou S; Oung P; Kong N; Pheap V; Thay K; Dao V; Kuntawunginn W; Feldman M; Gosi P; Buathong N; Ittiverakul M; Uthaimongkol N; Huy R; Spring M; Lek D; Smith P; Fukuda MM; Wojnarski M
    PLoS One; 2020; 15(1):e0228207. PubMed ID: 32004348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mystery of 'saturation gap' and falsely normal G6PD: a case of primaquine-induced haemolysis in Plasmodium vivax malaria infection.
    Tang ASO; Soo XY; Yeo ST; Mansor NA; Chew LP; Chua HH
    J R Coll Physicians Edinb; 2021 Jun; 51(2):146-148. PubMed ID: 34131671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination.
    Han KT; Han ZY; Aye KH; Wai KT; Thi A; Cui L; Sattabongkot J
    Trop Med Health; 2021 Jun; 49(1):47. PubMed ID: 34108049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China.
    Zeng W; Liu N; Li Y; Gao A; Yuan M; Ma R; Jiang N; Sun D; Wang G; Feng X
    Front Public Health; 2022; 10():1010172. PubMed ID: 36339224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic spectrum and clinical early natural history of glucose-6-phosphate dehydrogenase deficiency in Mexican children detected through newborn screening.
    Vela-Amieva M; Alcántara-Ortigoza MA; González-Del Angel A; Belmont-Martínez L; López-Candiani C; Ibarra-González I
    Orphanet J Rare Dis; 2021 Feb; 16(1):103. PubMed ID: 33637102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S; Pradines B; Basco LK
    Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.
    Peixoto HM; Brito MA; Romero GA; Monteiro WM; de Lacerda MV; de Oliveira MR
    Malar J; 2016 Feb; 15():82. PubMed ID: 26864333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose-6-phosphate dehydrogenase deficiency among malaria patients of Honduras: a descriptive study of archival blood samples.
    Zúñiga MÁ; Mejía RE; Sánchez AL; Sosa-Ochoa WH; Fontecha GA
    Malar J; 2015 Aug; 14():308. PubMed ID: 26249834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
    Baird JK; Battle KE; Howes RE
    Malar J; 2018 Jan; 17(1):42. PubMed ID: 29357870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients.
    Khim N; Benedet C; Kim S; Kheng S; Siv S; Leang R; Lek S; Muth S; Chea N; Chuor CM; Duong S; Kerleguer A; Tor P; Chim P; Canier L; Witkowski B; Taylor WR; Ménard D
    Malar J; 2013 May; 12():171. PubMed ID: 23714236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon.
    Santana MS; Monteiro WM; Siqueira AM; Costa MF; Sampaio V; Lacerda MV; Alecrim MG
    Trans R Soc Trop Med Hyg; 2013 May; 107(5):301-6. PubMed ID: 23479361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches.
    Shitaye G; Gadisa E; Grignard L; Shumie G; Chali W; Menberu T; Belachew M; Tegegn G; Challi S; Curry J; Mahey L; Hailu T; Mamo H; Menon M; Balcha T; Aseffa A; Drakeley C; Bousema T; Tadesse FG
    Malar J; 2018 Aug; 17(1):281. PubMed ID: 30071859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of glucose 6-phosphate dehydrogenase deficiency in highly malaria-endemic municipalities in the Brazilian Amazon: A region-wide screening study.
    Nascimento JR; Brito-Sousa JD; Almeida ACG; Melo MM; Costa MRF; Barbosa LRA; Ramos RN; Silva-Neto AV; Balieiro PCDS; Figueiredo EFG; Silva EL; Baia-da-Silva DC; Bassat Q; Romero G; Melo GC; Sampaio VS; Lacerda M; Monteiro W
    Lancet Reg Health Am; 2022 Aug; 12():100273. PubMed ID: 36776424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid diagnostic test for G6PD deficiency in Plasmodium vivax-infected men: a budget impact analysis based in Brazilian Amazon.
    Peixoto HM; Brito MA; Romero GA; Monteiro WM; de Lacerda MV; de Oliveira MR
    Trop Med Int Health; 2017 Jan; 22(1):21-31. PubMed ID: 27770602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
    Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
    PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and laboratorial alterations in Plasmodium vivax malaria patients and glucose-6-phosphate dehydrogenase deficiency treated with primaquine at 0.50 mg/kg/day].
    Silva MC; Santos EB; Costal EG; Filho MG; Guerreiro JF; Póvoa MM
    Rev Soc Bras Med Trop; 2004; 37(3):215-7. PubMed ID: 15330059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas.
    Howes RE; Chan ER; Rakotomanga TA; Schulte S; Gibson J; Zikursh M; Franchard T; Ramiranirina B; Ratsimbasoa A; Zimmerman PA
    Malar J; 2017 Apr; 16(1):139. PubMed ID: 28376871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
    Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
    PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primaquine treatment and relapse in Plasmodium vivax malaria.
    Rishikesh K; Saravu K
    Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.